ResearcherID - CLICK HERE

TITLE:

A COMPARATIVE RESEARCH TO EVALUATE MVA (MANUAL VACUUM ASPIRATION) AND MEDICAL TREATMENT TO MANAGE MISSED MISCARRIAGE (FIRST TRIMESTER)

AUTHORS:

Dr Zainab Bibi, Dr Yasir Ashfaq, Dr Saleha Javed

ABSTRACT:

Objective: The objective of this research is to evaluate and contrast the medical treatment and MVA (Manual Vacuum Aspiration) for managing the miscarriage in the 1st trimester. Material and Methods: This comparative research was conducted at Sir Ganga Ram Hospital, Lahore (August 2017 to March 2018). This research consists of a total of 92 cases of patients having a gestation age of less than twelve (12) weeks of missed abortion in the first trimester. Two groups were made of the patients: group A was treated with MVA whereas group B was treated medically and their effectiveness was evaluated. Results: The patients’ mean age was (29.77 ± 6.786) years in which group A patients’ mean age was (30.61 ± 6.754) years while group B patients’ mean age was (28.93 ± 6.787) years. The gestational mean age was (5.87 ± 3.592) weeks in which group A gestational mean age was (6.09 ± 3.699) weeks while group B gestational mean age was (5.65 ± 3.510) weeks. In group A patients, the effectiveness of treatment was 91.30% (42 out of 46 patients) while in the group B patients, the effectiveness of the treatment was 69.57% (32 out of 46 patients). The rate of effectiveness of cure for group A was considerably greater than Group B i.e., 91.30% as compared to 69.57%, having (p=0.009). Conclusion: The outcome of this research proved that MVA is a far more useful modality of treatment than medical treatment i.e., misoprostol intravaginally, as the rate of effectiveness of cure was considerably greater for the group of MVA than the group which was treated medically and it was especially true in the group of patients with older ages. Keywords: Evacuation and Dilatation, Incomplete Abortion and Manual Vacuum Aspiration.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.